Recruiting

Observational Study

Sponsor:

Weill Medical College of Cornell University

Code:

NCT02166086

Conditions

Diagnosis of a Pancreaticobiliary Disorder

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Endoscopy

Study Details

Brief summary:

The purpose of this registry is to record information and evaluate the impact of advanced imaging techniques on the management of pancreatico-biliary disorders. The registry will evaluate diagnostic performance and overall clinical management impacted by advanced imaging techniques.

Conditions

Diagnosis of a Pancreaticobiliary Disorder

Study ID

NCT02166086

Start date

Sep, 2011

Status verified date

Feb, 2017

Completion date

Dec 30, 2018

Anticipated

Primary completion date

Dec 1, 2018

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Any patient who has undergone advanced imaging procedures for diagnosis and/or treatment of a pancreatico-biliary disorder.
  • Above 18 years of age.

Exclusion Criteria:

  • Any patient who has not undergone advanced imaging techniques for pancreatico-biliary disorders.
  • Below 18 years of age.

Study Design

Enrollment

500 participants

Anticipated

Interventions and Outcome Measures

Arms

Endoscopic imaging

Any patient who has undergone advanced imaging procedures for diagnosis and/or treatment of a pancreatico-biliary disorder.

Interventions

Endoscopy

Endoscopy involving advanced imaging techniques

Primary outcome measure

  • Efficacy Profile [ Time Frame: 1 year ]

Central Contacts and Locations

Central contacts

Locations

Weill Cornell Medical College

Recruiting

New York, New York, United States, 10021

Contacts

Principal Investigator:

Michel Kahaleh, MD

More Information

Sponsor

Weill Medical College of Cornell University

Last update posted

Feb 20, 2017

Last verified

Feb, 2017

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Weill Medical College of Cornell University on 2017-02-20.